A trial emulation study indirectly comparing tafamidis and acoramidis in transthyretin amyloid cardiomyopathy: the ReplicATTR study

Philippe Debonnaire, Peter-Paul Zwetsloot, Roman Pfister, Pau Llàcer, Alberto Cipriani, Paolo Milani, Diana Bonderman, Christoph Ohlmeier, Thomas Evers, Richard Wyss, Elisabetta Patorno, Riddhi Doshi, Julien Beisel, Craig I Coleman, Carlos Aguiar, Tomas Ripoll-Vera

Open source

DOI: 10.57264/cer-2026-0114
Published: 2026-09-14
Container: Journal of Comparative Effectiveness Research
Publisher: Becaris Publishing Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.57264/cer-2026-0114,
  title = {A trial emulation study indirectly comparing tafamidis and acoramidis in transthyretin amyloid cardiomyopathy: the ReplicATTR study},
  author = {Philippe Debonnaire and Peter-Paul Zwetsloot and Roman Pfister and Pau Llàcer and Alberto Cipriani and Paolo Milani and Diana Bonderman and Christoph Ohlmeier and Thomas Evers and Richard Wyss and Elisabetta Patorno and Riddhi Doshi and Julien Beisel and Craig I Coleman and Carlos Aguiar and Tomas Ripoll-Vera},
  year = {2026},
  journal = {Journal of Comparative Effectiveness Research},
  doi = {10.57264/cer-2026-0114},
  url = {https://doi.org/10.57264/cer-2026-0114}
}

RIS

TY  - JOUR
TI  - A trial emulation study indirectly comparing tafamidis and acoramidis in transthyretin amyloid cardiomyopathy: the ReplicATTR study
AU  - Philippe Debonnaire
AU  - Peter-Paul Zwetsloot
AU  - Roman Pfister
AU  - Pau Llàcer
AU  - Alberto Cipriani
AU  - Paolo Milani
AU  - Diana Bonderman
AU  - Christoph Ohlmeier
AU  - Thomas Evers
AU  - Richard Wyss
AU  - Elisabetta Patorno
AU  - Riddhi Doshi
AU  - Julien Beisel
AU  - Craig I Coleman
AU  - Carlos Aguiar
AU  - Tomas Ripoll-Vera
PY  - 2026
JO  - Journal of Comparative Effectiveness Research
DO  - 10.57264/cer-2026-0114
UR  - https://doi.org/10.57264/cer-2026-0114
ER  -

APA

Debonnaire, P., Zwetsloot, P., Pfister, R., Llàcer, P., Cipriani, A., Milani, P., Bonderman, D., Ohlmeier, C., Evers, T., Wyss, R., Patorno, E., Doshi, R., Beisel, J., Coleman, C. I., Aguiar, C., & Ripoll-Vera, T. (2026). A trial emulation study indirectly comparing tafamidis and acoramidis in transthyretin amyloid cardiomyopathy: the ReplicATTR study. Journal of Comparative Effectiveness Research. https://doi.org/10.57264/cer-2026-0114

Source records

crossref · retrieved 2026-09-25T13:57:30.198Z